Global Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2012

Fore Pharma, October 2012, Pages: 24

Fore Pharma announced the results of its Age-Related Macular Degeneration patient population study in a new report ‘Global Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2012’. The report provides insights into Age-Related Macular Degeneration epidemiology, Age-Related Macular Degeneration diagnosed patients, and Age-Related Macular Degeneration treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Age-Related Macular Degeneration derived from epidemiological analysis, percentage of patients diagnosed with Age-Related Macular Degeneration, and percentage of patients treated with Age-Related Macular Degeneration therapy.

The study helps executives estimate Age-Related Macular Degeneration market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Age-Related Macular Degeneration prevalence, Age-Related Macular Degeneration diagnosis rate, and Age-Related Macular Degeneration treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:
- Age-Related Macular Degeneration: Disease Definition
- Age-Related Macular Degeneration Patient Flow
- Age-Related Macular Degeneration Prevalence
- Age-Related Macular Degeneration Diagnosed Patients
- Age-Related Macular Degeneration Treated Patients

1. Age-Related Macular Degeneration: Disease Definition
2. Global Age-Related Macular Degeneration Patient Flow
2A. Global Age-Related Macular Degeneration Prevalence
2B. Global Age-Related Macular Degeneration Diagnosed Patients
2C. Global Age-Related Macular Degeneration Treated Patients
3. Age-Related Macular Degeneration Patient Flow in the US
3A. Age-Related Macular Degeneration Prevalence in the US
3B. Age-Related Macular Degeneration Diagnosed Patients in the US
3C. Age-Related Macular Degeneration Treated Patients in the US
4. Age-Related Macular Degeneration Patient Flow in Europe
4A. Age-Related Macular Degeneration Prevalence in Europe
4B. Age-Related Macular Degeneration Diagnosed Patients in Europe
4C. Age-Related Macular Degeneration Treated Patients in Europe
5. Age-Related Macular Degeneration Patient Flow in Germany
5A. Age-Related Macular Degeneration Prevalence in Germany
5B. Age-Related Macular Degeneration Diagnosed Patients in Germany
5C. Age-Related Macular Degeneration Treated Patients in Germany
6. Age-Related Macular Degeneration Patient Flow in France
6A. Age-Related Macular Degeneration Prevalence in France
6B. Age-Related Macular Degeneration Diagnosed Patients in France
6C. Age-Related Macular Degeneration Treated Patients in France
7. Age-Related Macular Degeneration Patient Flow in Spain
7A. Age-Related Macular Degeneration Prevalence in Spain
7B. Age-Related Macular Degeneration Diagnosed Patients in Spain
7C. Age-Related Macular Degeneration Treated Patients in Spain
8. Age-Related Macular Degeneration Patient Flow in Italy
8A. Age-Related Macular Degeneration Prevalence in Italy
8B. Age-Related Macular Degeneration Diagnosed Patients in Italy
8C. Age-Related Macular Degeneration Treated Patients in Italy
9. Age-Related Macular Degeneration Patient Flow in UK
9A. Age-Related Macular Degeneration Prevalence in UK
9B. Age-Related Macular Degeneration Diagnosed Patients in UK
9C. Age-Related Macular Degeneration Treated Patients in UK
10. Age-Related Macular Degeneration Patient Flow in Japan
10A. Age-Related Macular Degeneration Prevalence in Japan
10B. Age-Related Macular Degeneration Diagnosed Patients in Japan
10C. Age-Related Macular Degeneration Treated Patients in Japan
11. Appendix
12. Research Methodology
12A. Sources

Table 1: Global Age-Related Macular Degeneration Patient Flow (2012)
Table 2: Global Age-Related Macular Degeneration Patient Flow Forecast (2012-2019)
Table 3: Age-Related Macular Degeneration Patient Flow in the US (2012)
Table 4: Age-Related Macular Degeneration Patient Flow Forecast in the US (2012-2019)
Table 5: Age-Related Macular Degeneration Patient Flow in Europe (2012)
Table 6: Age-Related Macular Degeneration Patient Flow Forecast in Europe (2012-2019)
Table 7: Age-Related Macular Degeneration Patient Flow in Germany (2012)
Table 8: Age-Related Macular Degeneration Patient Flow Forecast in Germany (2012-2019)
Table 9: Age-Related Macular Degeneration Patient Flow in France (2012)
Table 10: Age-Related Macular Degeneration Patient Flow Forecast in France (2012-2019)
Table 11: Age-Related Macular Degeneration Patient Flow in Spain (2012)
Table 12: Age-Related Macular Degeneration Patient Flow Forecast in Spain (2012-2019)
Table 13: Age-Related Macular Degeneration Patient Flow in Italy (2012)
Table 14: Age-Related Macular Degeneration Patient Flow Forecast in Italy (2012-2019)
Table 15: Age-Related Macular Degeneration Patient Flow in UK (2012)
Table 16: Age-Related Macular Degeneration Patient Flow Forecast in UK (2012-2019)
Table 17: Age-Related Macular Degeneration Patient Flow in Japan (2012)
Table 18: Age-Related Macular Degeneration Patient Flow Forecast in Japan (2012-2019)

Figure 1: Global Age-Related Macular Degeneration Patient Flow (2012)
Figure 2: Global Age-Related Macular Degeneration Patient Flow Forecast (2012-2019)
Figure 3: Age-Related Macular Degeneration Patient Flow in the US (2012)
Figure 4: Age-Related Macular Degeneration Patient Flow Forecast in the US (2012-2019)
Figure 5: Age-Related Macular Degeneration Patient Flow in Europe (2012)
Figure 6: Age-Related Macular Degeneration Patient Flow Forecast in Europe (2012-2019)
Figure 7: Age-Related Macular Degeneration Patient Flow in Germany (2012)
Figure 8: Age-Related Macular Degeneration Patient Flow Forecast in Germany (2012-2019)
Figure 9: Age-Related Macular Degeneration Patient Flow in France (2012)
Figure 10: Age-Related Macular Degeneration Patient Flow Forecast in France (2012-2019)
Figure 11: Age-Related Macular Degeneration Patient Flow in Spain (2012)
Figure 12: Age-Related Macular Degeneration Patient Flow Forecast in Spain (2012-2019)
Figure 13: Age-Related Macular Degeneration Patient Flow in Italy (2012)
Figure 14: Age-Related Macular Degeneration Patient Flow Forecast in Italy (2012-2019)
Figure 15: Age-Related Macular Degeneration Patient Flow in UK (2012)
Figure 16: Age-Related Macular Degeneration Patient Flow Forecast in UK (2012-2019)
Figure 17: Age-Related Macular Degeneration Patient Flow in Japan (2012)
Figure 18: Age-Related Macular Degeneration Patient Flow Forecast in Japan (2012-2019)

Customers who bought this item also bought

• Global Age-Related Macular Degeneration Drug Pipeline Capsule - 2012
• Special Report: Thought-Leader Opinion on the Current and Future Landscape of the Age-Related Macular Degeneration Market
• Medical Nutrition - A Global Market Overview
• Global Ophthalmic Market: Focus on Diagnostics and Surgical Equipments
• Wheelchairs (Powered and Manual) - Global Strategic Business Report
• Disinfectants - Global Strategic Business Report
• Bariatric (Obesity) Surgical Devices - Global Strategic Business Report
• Diabetes Diagnostics - Global Strategic Business Report
• The Incidence and Prevalence Database: Global Incidence, Prevalence, Morbidity, Comorbidity, Cost Data, Symptoms and Many Other Health Issues for over 4,500 Diseases and Procedures
• Molecular Diagnostics - Global Strategic Business Report